HLD Europe completes the sale of a 9.77% stake in Exosens to THEON INTERNATIONAL
January 8, 2026
Acquisitions and disposals
Paris, 7 January 2026 – Press Release
HLD Europe, the European investment group, announces it has completed the sale of a 9.77% stake in the share capital of Exosens to THEON INTERNATIONAL, a leading European manufacturer of advanced night vision optronic systems, in accordance with the agreement previously entered into and announced on 13 October 2025. The sale had been agreed at a price of €54 per share.
Following completion of this sale, HLD Europe holds 22.35% of the share capital and of the theoretical voting rights of Exosens.